Cancer Imaging· 2026Q1
Multiparametric MRI-based habitat radiomics integrated with a vision transformer for preoperative prediction of p53 status in endometrial cancer
- 0citations
- Q1SCImago
- 2026year
Short summary
A fusion model integrating MRI-based habitat radiomics and a Vision Transformer (ViT) accurately predicts p53 status in endometrial cancer (EC) preoperatively, achieving AUCs of 0.881-0.904 across validation cohorts.
AI-generated from the title and abstract; the full text is not read.
Key points
- A fusion model integrating MRI habitat radiomics, ViT-extracted deep learning features, and clinical predictors accurately predicted p53-abnormal status in endometrial cancer.
- The fusion model achieved high performance with AUCs of 0.881 (internal validation), 0.869, and 0.904 (external validation).
- Habitat radiomics alone outperformed standard radiomics, with AUCs ranging from 0.770–0.802.
- SHAP analysis confirmed significant contributions from habitat and deep learning features.
- Exploratory analysis revealed that the fusion model's predicted p53 status was an independent predictor of progression-free survival.
AI-generated from the title and abstract; the full text is not read.
Abstract
To develop a multiparametric MRI-based fusion model integrating habitat radiomics with a Vision Transformer (ViT) to preoperatively predict p53 status in endometrial cancer (EC), and to explore its potential prognostic relevance. From three centers, this retrospective study analyzed 1,230 patients with EC, assigned to a training cohort ( n = 447), an internal validation cohort ( n = 192), and two external validation cohorts ( n = 246 and 345). We used the tumor and habitat regions to extract radiomics features. Deep learning (DL) features were extracted using the ViT model. Clinical, radiomics, habitat, ViT, and fusion models were constructed based on the support vector machine algorithm. Interpretability was enhanced using SHapley Additive Explanations (SHAP) analysis, and prognostic value for progression-free survival (PFS) was further evaluated. p53-abnormal (p53abn) immunophenotype was identified in 232 patients (18.9%). The maximum tumor diameter and histologic grade were selected as clinical predictors of p53abn status. The habitat model attained areas under the curve (AUCs) of 0.770–0.802 in the validation cohorts, outperforming the radiomics model. A fusion model integrating the habitat radiomics and DL features with clinical predictors achieved the optimal performance, with AUCs of 0.881, 0.869, and 0.904 in the internal and two external validation cohorts, respectively. SHAP analysis indicated that the habitat and DL features made significant contributions to p53abn EC prediction. Exploratory survival analysis showed that fusion-model–predicted p53 status was independently associated with PFS. The fusion model may serve as a complementary imaging tool for preoperative assessment of p53 status in EC.
The authors' abstract, as published at the source. Cancer Imaging, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Obstetrics and Gynecology
Obstetrics and GynecologyMedicine